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Abstract 
Background: This study aimed to evaluate the compatibility of robotic single-site (RSS) myomectomy in comparison 
with the conventional robotic multi-port (RMP) myomectomy to achieve successful surgical outcomes with reliability 
and reproducibility.
Methods: This retrospective case–control study was performed on 236 robotic myomectomies at a university medi-
cal center. After 1:1 propensity score matching for the total myoma number, total myoma diameter, and patient age, 
90 patients in each group (RSS: n = 90; RMP: n = 90) were evaluated. Patient demographics, preoperative parameters, 
intraoperative characteristics, and postoperative outcome measures were analyzed.
Results: The body mass index, parity, preoperative hemoglobin levels, mean maximal myoma diameter, and ana-
tomical type of myoma showed no mean differences between RSS and RMP myomectomies. The RSS group was 
younger, had lesser number of myomas removed, and had a smaller sum of the maximal diameter of total myomas 
removed than the RMP group. After propensity score matching, the total operative time (RSS: 150.9 ± 57.1 min vs. 
RMP: 170 ± 74.5 min, p = 0.0296) was significantly shorter in the RSS group. The RSS group tended to have a longer 
docking time (RSS: 9.8 ± 6.5 min vs. RMP: 8 ± 6.2 min, p = 0.0527), shorter console time (RSS: 111.1 ± 52.3 min vs. 
RMP: 125.8 ± 65.1 min, p = 0.0665), and shorter time required for in-bag morcellation (RSS: 30.1 ± 17.2 min vs. RMP: 
36.2 ± 25.7 min, p = 0.0684). The visual analog scale pain score 1 day postoperatively was significantly lower in the RSS 
group (RSS: 2.4 ± 0.8 days vs. RMP: 2.7 ± 0.8 days, p = 0.0149), with similar consumption of analgesic drugs. The rate 
of transfusion, estimated blood loss during the operation, and length of hospital stay were not different between the 
two modalities. No other noticeable complications were observed in either group.
Conclusions: Da Vinci RSS myomectomy is a compatible option with regard to reproducibility and safety, without 
significantly compromising the number and sum of the maximal diameter of myomas removed. The advantage of 
shorter total operative time and less pain with the same amount of analgesic drugs in RSS myomectomy will contrib-
ute to improving patient satisfaction.
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Background
Uterine myomas are diagnosed in approximately 
25–40% of women during the reproductive age, causing 
menorrhagia, dysmenorrhea, anemia, pressure symp-
toms due to mass effect, and possible pregnancy-related 
complications [1, 2]. When conservative, symptomatic 
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treatment for myomas fails in those wishing to preserve 
fertility, a laparotomy, laparoscopy, or robot-guided 
myomectomy is the preferred choice. Myomectomy 
using minimally invasive surgery (MIS) techniques 
has important advantages with regard to postoperative 
morbidity and the speed of recovery, with less intra-
operative blood loss and shorter hospital stays [3, 4]. 
However, the limitations of ergonomics, longer learn-
ing curves, and uterine dehiscence after pregnancy due 
to suboptimal suture conditions are the main concerns 
regarding laparoscopic myomectomy, especially for 
deep intramural myomas [5]. When the lowest number 
of ports is desired, single-incision laparoscopy-guided 
myomectomy could also be performed; however, the 
added limitations of the degree of freedom for surgical 
tool manipulation have hindered its widespread appli-
cation [6].
With the introduction of robot-guided surgery, which 
provides stereoscopic binocular vision, absorption of 
physiologic hand tremors, and wristed motion of surgi-
cal tools, minimally invasive gynecologic surgery has 
become more sophisticated. Robot-guided myomectomy 
has been accepted as a reproducible, safe, and success-
ful means of resecting myomas without compromising 
the quality of the operative procedure, with delicate tools 
available for adequate myometrial sutures [7, 8]. How-
ever, the demand for using the lowest number of ports 
to induce compatible surgical outcomes has always been 
sought out in gynecologic surgery due to poorer cosme-
sis, higher costs, and the complexity of robotic multi-
port (RMP) surgery compared to traditional single-port 
incision laparoscopic surgery [9, 10].
With the availability of robotic single-site (RSS) surgery 
using the Da Vinci Si system, hysterectomies and adnexal 
surgeries are the ones that have mainly been performed; 
however, myomectomies performed using the single-site 
system are also emerging procedures [11, 12]. Neverthe-
less, there is a lack of research and more challenges to 
overcome pertaining to RSS compared to RMP surgery, 
which is still the most commonly used robot-assisted 
approach [13]. With the initial set of non-wristed tools, 
the applicability of the RSS system for a wide range of 
gynecologic procedures had been questioned in prelimi-
nary reports [14]. However, with the addition of single-
site wristed needle drivers, limitations in tissue handling 
and suture placement have been significantly overcome, 
where the 45° angulation with rotation provides better 
precision for driving the needle with more ease. When 
the characteristics of the single-site tools are properly 
managed, maintaining optimal triangulation between the 
robotic arms and the accessory port becomes possible 
with minimal collision of the tools, as frequently experi-
enced with single-incision laparoscopy.
Single-site myomectomy provides additional benefits 
regarding the concerns over power-morcellated myoma 
extraction that began in 2013 [15–18]. The relative ease 
of in-bag manual morcellation of myomas via the 2.5-cm 
umbilical port and not having to modify port incision are 
major favorable aspects of RSS myomectomy. However, 
the choice of tools available for single-site procedures at 
present is less diverse, and the time required to skillfully 
coordinate the robotic arms with the assistant’s accessory 
port is usually longer. Validating whether Da Vinci RSS 
myomectomy is a reproducible and reliable method with 
successful surgical outcomes is a subject that needs to be 
addressed.
By performing a comparative analysis between the Da 
Vinci conventional RMP and RSS myomectomies per-
formed at a university medical center, we aim to dem-
onstrate whether the RSS procedure is compatible with 
regard to the number, size, and location of the resected 
myomas, as well as the technical reproducibility, safety, 
and surgical outcomes of the procedure.
Methods
Patient selection and surgical team
A total of 236 patients who, in the attempt to preserve 
their fertility, underwent the Da Vinci Si (Intuitive Sur-
gical, Sunnyvale, CA, USA) procedure between October 
2016 and May 2021 at the Department of Obstetrics and 
Gynecology, Gangnam Severance Hospital, Yonsei Uni-
versity College of Medicine, Seoul, Korea, were included 
in this retrospective case–control analysis. Detailed 
patient characteristics including demographics, indica-
tions for surgery, intraoperative findings, and periop-
erative laboratory findings were reviewed and analyzed. 
Pelvic ultrasonography and/or magnetic resonance 
imaging were performed preoperatively (Fig.  1A) and 
3  months postoperatively. For both types of surgeries, 
myomas of International Federation of Gynecology and 
Obstetrics (FIGO) type 2–7 were candidates for surgery, 
whereas patients with uteri greater in size than the size at 
16 gestational weeks, those with extensive degenerative 
changes, or those with necrotic features present on imag-
ing were excluded. Patients with more than 15 myomas 
were primarily recommended to undergo laparotomy 
over MIS. Patients requiring simultaneous intervention 
for other pelvic or abdominal conditions were excluded 
from the analysis. Furthermore, patients who had previ-
ously undergone laparotomies or those with suspected 
severe pelvic or abdominal adhesions were excluded. 
The surgical team was led by the same supervising sur-
geon who began the Da Vinci robotic surgery as a fel-
low in training 10  years ago, with 4  years of experience 
as the main operator. The supervising surgeon also had a 
12-year experience in gynecologic laparoscopy.
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Operating room setup and surgical procedure
Under general endotracheal anesthesia, a patient was 
placed in a dorsal lithotomy and Trendelenburg position. 
A Rumi uterine manipulator (Cooper Surgical, Trumbull, 
CT, USA) was inserted into the uterine cavity.
For the single-site surgery, the standard Da Vinci 




Fig. 1 A stepwise description of a representative robotic single-site myomectomy case. Myomectomy was recommended for a 32 year-old 
woman due to menorrhagia and infertility for a period of 14 months. To decrease the size of this 8.5-cm FIGO type 3 myoma, leuprolide acetate was 
injected, but surgery could not be postponed due to intolerable heavy vaginal bleeding for 3 weeks. A Due to the unusual amount of bleeding 
and suspected distortion of the uterine cavity on ultrasonography, a pelvic magnetic resonance imaging was performed prior to the surgery 
(T2-weighted image). B A view of the operating field after docking of the Da Vinci Si single-site platform, with the first assistant to the right of the 
patient controlling the assistant port. The maintenance of this configuration of the robotic arms is important to create adequate triangulation 
intra-abdominally and to minimize tool clashing. C The myometrial incision was placed with a monopolar hook. D Although the robotic tools for 
the single-site platform have less variety, skillful use of bipolar forceps, the hook, and/or the wristed needle driver allows for adequate dissection. E 
Suturing was performed with V-locks in three layers, involving deep myometrial sutures to achieve adequate approximation and to prevent dead 
spaces from forming within the myometrium. F Although the serosal layer is most commonly approximated with Vicryls, when barbed suture 
materials are used, continuous sutures are placed so that the barbing is not exposed, and an anti-adhesive film is covered at the end. G Manual 
in-bag morcellation of the myoma with spiral incisions through the 2.5-cm umbilical port. H The 2.5-cm umbilical incision immediately after closure
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a 2.5-cm vertical incision on the umbilicus, with the 
two robotic cannulas crossing each other to create an 
intraperitoneal triangulation, and the 5-mm or 10-mm 
accessory cannulas controlled by the assistant were 
interchanged depending on the surgical material to be 
inserted. An 8.5-mm 30° high-definition camera was 
inserted via the camera port. Before continuing with the 
docking process, the pelvic and abdominal cavities were 
carefully inspected to check for any contraindications for 
the selected procedure. With the robot docked in place 
(Fig. 1B), the semi-rigid tools that were inserted through 
the curved robotic cannula to the left of the camera 
appeared to the right of the video screen and were oper-
ated with the surgeon’s right hand and vice versa. Such 
orientation of the single-site cannulas marks the key fea-
ture of a Da Vinci single-site surgery, which overcomes 
the limitations experienced by single-incision laparo-
scopic surgery. The set of tools used for the myomectomy 
procedure consisted of a monopolar hook, fenestrated 
bipolar forceps, and a wristed needle driver. Although 
possible, a second arm, to use the tenaculum, was not 
utilized for any of the cases. After the injection of diluted 
vasopressin when necessary, a uterine incision was made 
using the monopolar hook. The bipolar forceps and the 
monopolar hook were used to extract the myomas, while 
simultaneously controlling the bleeding along with the 
dissection process (Fig. 1C, D). When additional traction 
was required, a 5-mm myoma screw was controlled by 
the first assistant through the accessory port.
For the multi-port procedure, a 30° 12-mm camera was 
used, and the 8-mm trocar for the first robotic arm was 
placed at 8 cm left lateral and 2 cm caudal and that for 
the second robotic arm was placed at 8 cm right lateral 
and 2 cm caudal to the umbilical camera port. A 10-mm 
accessory port was placed in the left lower quadrant for 
the first assistant for manipulation. Myoma traction was 
achieved using the robotic tenaculum via robotic arm 1 
or 2. The third arm was not used in any of the myomec-
tomy cases.
Depending on the FIGO classification and the ana-
tomic location of the myoma, the uterine layers were 
repaired in two to four layers; the myometrium, with 
#1-0  V-lock barbed sutures; and the serosa, with #2-0 
Vicryls or #2-0  V-lock by continuous intracorporeal 
sutures using the conventional wristed needle driver and 
the single-site wristed needle driver, respectively (Fig. 1E, 
F). The myomas were extracted by manual knife morcel-
lation in a polyvinyl bag via the umbilicus for the single-
site procedure (Fig. 1G) and through the accessory port 
for the multi-port procedure, by extending the initial 
incision when exposure was inadequate. After thorough 
irrigation, either an anti-adhesive film or solution was left 
in the abdominal cavity, and a silastic drain was inserted 
through the 8-mm incision for the multi-port and at 
the lower tip of the umbilical incision for the single-site 
procedure when necessary. The umbilical incision was 
approximated using interrupted sutures (Fig. 1H).
Postoperative hemoglobin levels were checked rou-
tinely on postoperative day 1 and immediately when the 
intraoperative estimated blood loss was over 500 mL or 
signs of hypovolemia were present. The length of hospital 
stay was calculated as the period from the day of surgery 
to the date of discharge. The visual analog scale (VAS) 
for pain was assessed on days 1 and 2 after surgery. An 
intravenous patient-controlled analgesia (PCA) machine 
was used as soon as the surgery was completed. The PCA 
medication was prepared by an anesthesiologist with 
fentanyl based in a total volume of 100  mL. There was 
continuous background infusion throughout the post-
operative period, and patients were encouraged to self-
administer their own PCA medications of 1-mL bolus 
at a time if additional pain control was required, and 
self-administration was blocked for 5 min. Patients were 
intravenously administered pethidine at 25 mg or trama-
dol at 50 mg when they requested an additional analgesic. 
The cumulative PCA infusion volume and other analge-
sic medication requirements up to the second day after 
surgery were recorded by the medical staff. To compare 
the equianalgesic dose, the total fentanyl dose was cal-
culated as the initial mixing dose of fentanyl multiplied 
by the total infused volume of the PCA medication, and 
other analgesic drug consumptions were added after 
conversion to fentanyl equivalents (1 mg tramadol intra-
venous/intramuscular is equivalent to 1  mcg fentanyl, 
1 mg demerol intravenous/intramuscular is equivalent to 
2.4 mcg fentanyl) [19]. All analgesic drug consumptions 
were summed after conversion to fentanyl equivalents. 
Follow-up visits were on postoperative day 7, at 3 and 
9 months, and onwards, to perform imaging of the uterus 
and monitor any complications.
Statistical analysis
Data were analyzed using the Kolmogorov–Smirnov test 
or Shapiro–Wilk test to assess normal distribution and 
were compared using the t-test for continuous variables. 
The Chi-square or Fisher’s exact test was used for cate-
gorical variables, as appropriate, before propensity score 
matching. For the analysis to be with minimized selec-
tion bias, 1:1 propensity score matching was performed 
for the total myoma number, total maximal diameter, and 
age between the RSS and RMP groups. A nearest-neigh-
bor-matching algorithm was used along with the logit of 
their propensity score, with matching occurring if the dif-
ference in the logits of the propensity scores was less than 
0.2 times the standard deviation of the scores (the cali-
per width). After propensity score matching, the paired 
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t-test or McNemar’s test was used to compare the clinical 
parameters wherever appropriate. All statistical analyses 
were conducted using SAS version 9.4 (SAS Inc., Cary, 
NC, USA). Statistical significance was set at p < 0.05.
Results
A total of 236 patients who underwent Da Vinci Si 
system-guided robotic myomectomies and had fully 
received routine postoperative follow-ups were analyzed. 
Among the 236 patients, 107 (45.3%) underwent RSS 
myomectomies and 129 (54.7%) received conventional 
RMP myomectomies. The RSS group was younger, had 
lesser number of myomas removed, and had a smaller 
sum of the maximal diameter of total myomas removed. 
No significant difference was observed in the propor-
tion of obese patients with body mass index (BMI) more 
than 25  kg/m2, parity, preoperative hemoglobin levels, 
maximal diameter of myomas, and location of myomas 
according to the FIGO staging between the RSS and 
RMP myomectomy groups (Table 1).
Since the number of myomas removed, sum of the 
maximal diameter of total myomas removed, and age 
would consequently affect surgical outcomes, we per-
formed 1:1 propensity score matching for these three 
factors to minimize selection bias. After propen-
sity matching, the number of myomas removed (RSS: 
2.7 ± 2.4 vs. RMP: 2.8 ± 2.3, p = 0.4345), sum of the maxi-
mal diameter of total myomas (RSS: 11.5 ± 8 cm vs. RMP: 
11.9 ± 7.3  cm, p = 0.683), and age (RSS: 36.1 ± 6.5  years 
vs. RMP: 37 ± 5.8, p = 0.2648) showed no significant dif-
ferences between the RSS and RMP groups, with 90 
patients remaining in each group (Table 2).
As a result, total operative time (RSS: 150.9 ± 57.1 min 
vs. RMP: 170 ± 74.5  min, p = 0.0296) was significantly 
shorter for the single-site process. Although not sta-
tistically significant, the RSS group tended to have 
a longer docking time (RSS: 9.8 ± 6.5  min vs. RMP: 
8 ± 6.2  min, p = 0.0527), shorter console time (RSS: 
111.1 ± 52.3 min vs. RMP: 125.8 ± 65.1 min, p = 0.0665), 
and shorter time required for in-bag morcellation (RSS: 
30.1 ± 17.2  min vs. RMP: 36.2 ± 25.7  min, p = 0.0684). 
Postoperative hemoglobin levels resulting from the loss 
of intraoperative blood did not result in a significant 
difference between the two groups. The length of hos-
pitalization did not differ between the two surgical pro-
cedures. The VAS pain score 1 day postoperatively was 
significantly lower in the RSS group (RSS: 2.4 ± 0.8 days 
vs. RMP: 2.7 ± 0.8  days, p = 0.0149). The VAS pain 
scores 2  days postoperatively and the total amount of 
analgesic drugs used, which was calculated by convert-
ing the dose based on fentanyl, showed no differences 
between the two surgical procedures. There was one 
case of intraoperative conversion to open myomec-
tomy in the RMP group, but it was excluded after the 
propensity score matching (Table  3). For 235 of the 
236 cases analyzed, the pathologic reports confirmed 
the diagnosis of leiomyomas, except in one woman in 
whom a stromal tumor of unknown malignant poten-
tial (STUMP) was diagnosed, and a subsequent hys-
terectomy was performed 4 weeks later in this 41-year 
old uniparous woman. No remarkable perioperative 
complications other than postoperative anemia were 
observed in either group, and the rate of transfusion 
did not differ between the two modalities.
Table 1 Patient characteristics
p-values < 0.05 are statistically significant. Data are presented as mean ± standard deviation or n (%) values
DV Da Vinci, BMI body mass index, FIGO International Federation of Gynecology and Obstetrics
Parameters DV single-site myomectomy 
(N = 107)
DV multi-port myomectomy 
(N = 129)
p-value
Age (years) 35.9 ± 6.4 37.5 ± 5.7 0.0352
BMI (kg/m2) 0.3458
 < 25 89 (83.18) 101 (78.29)
 ≥ 25 18 (16.82) 28 (21.71)
Parity 0.3 ± 0.7 0.3 ± 0.7 0.4557
Preoperative hemoglobin level (g/dL) 12.5 ± 1.6 12.5 ± 1.7 0.9222
Number of myomas 2.5 ± 2.2 4.1 ± 3.7 0.0001
Maximal diameter of myomas (cm) 7.7 ± 2.8 7.7 ± 3 0.9217
Sum of maximal diameter of total myomas (cm) 11.3 ± 7.5 16 ± 10.3 < 0.0001
Anatomical type of myomas (%) 0.156
 FIGO type 2–3 62 (57.9) 61 (47.3)
 FIGO type 4–5 18 (16.8) 34 (26.4)
 FIGO type 6–7 27 (25.2) 34 (26.4)
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Discussion
The combination of technique and technology is an asset 
of contemporary gynecologic surgery, and there is con-
stant interest in accomplishing compatible surgical out-
comes with minimal number and size of incisions as 
well as in finding a more ideal site of entry to the target 
organ. With the advent of robot-assisted surgery, the 
comparison among laparotomy, laparoscopic, and multi-
port Da Vinci guided myomectomy has always been a 
subject of interest. With respect to reproducibility, safety, 
duration of the procedures, length of hospitalization, 
perioperative blood loss, likelihood of receiving transfu-
sions, and fertility outcomes, RMP myomectomies have 
been reported to yield favorable outcomes, compared 
Table 2 Patient characteristics after 1:1 propensity score matching
p-values < 0.05 are statistically significant. Data are presented as mean ± standard deviation or n (%) values
DV Da Vinci, BMI body mass index, FIGO International Federation of Gynecology and Obstetrics
Parameters DV single-site myomectomy 
(N = 90)
DV multi-port myomectomy 
(N = 90)
p-value
Age (years) 36.1 ± 6.5 37 ± 5.8 0.2648
BMI (kg/m2) 0.84739
 < 25 75 (83.3) 74 (82.2)
 ≥ 25 15 (16.7) 16 (17.8)
Parity 0.2 ± 0.6 0.4 ± 0.8 0.0771
Preoperative hemoglobin level (g/dL) 12.5 ± 1.6 12.5 ± 1.8 0.9861
Number of myomas 2.7 ± 2.4 2.8 ± 2.3 0.4345
Maximal diameter of myomas (cm) 7.6 ± 2.6 7.3 ± 2.9 0.683
Sum of maximal diameter of total myomas (cm) 11.5 ± 8 11.9 ± 7.3 0.6055
Anatomical type of myomas (%) 0.4132
 FIGO type 2–3 52 (57.8) 41 (45.6)
 FIGO type 4–5 15 (16.7) 24 (26.7)
 FIGO type 6–7 23 (25.6) 25 (27.8)
Table 3 Intraoperative and postoperative parameters after 1:1 propensity score matching
Data are presented as mean ± standard deviation or n (%) values
DV Da Vinci, VAS Visual analog scale
a For total amount of analgesics used, all analgesic drug consumptions were summed up after being converted to fentanyl equivalents
Parameters DV single-site myomectomy 
(N = 90)
DV multi-port myomectomy 
(N = 90)
p-value
Docking time (min) 9.8 ± 6.5 8 ± 6.2 0.0527
Console time (min) 111.1 ± 52.3 125.8 ± 65.1 0.0665
Morcellation time (min) 30.1 ± 17.2 36.2 ± 25.7 0.0684
Total operating time (min) 150.9 ± 57.1 170 ± 74.5 0.0296
Estimated blood loss (mL) 321.3 ± 316.5 414.8 ± 415.3 0.0634
Postoperative day 1 hemoglobin (g/dL) 9.9 ± 1.5 9.7 ± 1.5 0.4593
Length of stay (days) 4.03 ± 1 4.19 ± 1.4 0.3846
Postoperative pain score on day 1 (VAS) 2.4 ± 0.8 2.7 ± 0.8 0.0149
Postoperative pain score on day 2 (VAS) 1.9 ± 0.8 2.1 ± 0.8 0.0811
Total amount of analgesic  useda (μg) 961.9 ± 196 988.7 ± 144.5 0.2728
Conversion to another surgical method 0 0
Complications 20 (22.2) 29 (32.2) 0.1282
Immediate postoperative anemia 20 (100) 28 (96.5)
Wound dehiscence 0 0
Others 0 1 (3.4%)
Perioperative transfusion rate (%) 14 (15.6) 14 (15.6)  > 0.9999
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with laparotomy or laparoscopic myomectomies [7, 20, 
21]. However, longer operative time, higher costs, and 
the frequent need for larger and higher numbers of ports 
have been discussed as unfavorable features of RMP over 
laparoscopic myomectomies [20–22]. With the addi-
tion of the Da Vinci single-site platform, requiring only 
a single umbilical incision, this system has been utilized 
to perform total laparoscopic hysterectomy, laparoscopic 
supra-cervical hysterectomy, salpingo-oophorectomy, 
ovarian cystectomy, and excision of endometriosis; fur-
thermore, myomectomies using single-port systems 
have also been reported [12, 23, 24]. Novel methods have 
always been challenged over conventional techniques and 
have been tested over time before they are accepted as 
standardized methods. In the initial series of RSS surger-
ies, the procedures were performed using needle drivers 
in the absence of wrist motion, limiting their indications. 
However, with the subsequent introduction of wristed 
needle drivers as well as bipolar energy devices, more 
versatility has been added to the process with improved 
freedom of motion; therefore, the value of the current 
form of RSS for a variety of gynecologic procedures 
should be addressed.
This retrospective case–control study of RSS versus 
RMP myomectomy suggests that the single-site tech-
nique offers sound results without compromising the 
burden of the number and diameter of myomas as well 
as the anatomical type of myomas to be resected. The 
results of the present study correspond well with those 
of a recent systematic review that includes four stud-
ies supporting the safety of RSS myomectomy and its 
equivalency with the multi-port technique in terms of 
the most studied outcomes [25]. Two of the four studies 
were comparative studies [13, 26], and one of these stud-
ies conducted propensity score matching [26]. No dif-
ference was detected by both studies in the mean total 
operative time (145.9% vs. 147.3% and 83.3% vs. 109.2%, 
respectively). In addition to prior research, in our study, 
the total operative time was shorter in the RSM group 
than in the RMP group after propensity score matching. 
Several factors may account for the shorter duration of 
surgery. Unlike laparoscopic procedures, the surgeon is 
at the console, away from the surgical field, and a verbal 
order is placed for the first assistant to change the tools 
via the robotic arms. Typically, four to five robotic tools, 
including at least bipolar forceps, monopolar scissors, a 
tenaculum, and a needle driver, are interchanged by the 
assistant, consuming a significant amount of time, which 
has been addressed by other authors [20]. However, for 
the Da Vinci Si single-site platform, this waiting time is 
significantly reduced and the overall course is simplified, 
as virtually only bipolar forceps and a monopolar hook 
are used without substitution and are later changed to a 
wristed needle driver for approximation of the myome-
trium. Moreover, the time required for trans-umbilical 
manual morcellation of the myoma was considerably 
shorter in the RSS group (Table 2).
Several technical tips were accumulated for perform-
ing the RSS procedures. Depending on the abdominal 
wall thickness, the incision has to be extended beyond 
2.5 cm, as the upper and lower rims of the silicone port 
are larger in diameter and in an hourglass shape and an 
Alexis retractor is useful for compressing the abdomi-
nal wall. An overzealous attempt to keep the incision 
as small as possible may cause circular abrasions on the 
skin caused by the silicone, due to the pivoting of the 
robotic tools, leading to a considerable amount of dis-
comfort afterwards. When the robotic tools require 
more rigidity upon dissection, the length of the robotic 
cannula can be adjusted during the procedure to act as 
a rigid sheath covering the semi-rigid tools. The wristed 
needle driver has a smaller range of motion, with flexion 
of approximately 45°; however, unlike what is expected, 
when proper accommodation is accomplished, very lit-
tle limitation in needle driving is experienced (Fig.  1F). 
For cases where suture placement is more difficult, two 
wristed needle drivers could be used for better manipula-
tion of both tissue and suture materials. Unlike hysterec-
tomies or adnexal surgeries where the removal of surgical 
specimens can be performed either via the vagina or the 
consistency of the mass allows for easy extraction, myo-
mas are more difficult to extract through a small inci-
sion. Thus, powered morcellation has been widely used 
to facilitate the myoma extraction process. However, with 
a warning released in 2014 [15–18], methods for remov-
ing myomas after a minimally invasive myomectomy 
have been debated [27–29]. The Da Vinci single-site sys-
tem could provide exemption from this burden in speci-
men extraction, where manual in-bag knife morcellation 
through a 2.5-cm umbilical incision is relatively easy to 
accomplish (Fig. 1G). In certain circumstances, the semi-
rigid nature of RSS tools provides several benefits for the 
surgical process. The tools are less traumatic upon tissue 
handling and consider the absence of tactile sensation for 
the surgeon at the console, which helps to prevent tearing 
or puncturing tissues during the dissection process. This 
characteristic is especially useful for FIGO type 2 myo-
mas, where unwanted disruption of the endometrial cav-
ity upon dissection with robotic tools can be minimized.
Previous studies reported significantly prolonged 
hospital stays in patients who underwent a single-site 
approach than in those who underwent multi-site ones 
[13, 26]. However, there were no differences in the 
length of hospital stay between the two groups. During 
a patient’s hospitalization, there was no significant differ-
ence in the amount of analgesic drugs used and the pain 
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scores on the second day after surgery between the two 
groups. Interestingly, the pain score on the first day after 
surgery was significantly lower in the RSS group. This 
lower pain score may be attributed to a shorter operative 
time and less abdominal muscle tension-induced pain 
with reduced number of incision sites. Reaching a lower 
pain score more quickly may contribute to improving a 
patient’s satisfaction with surgery.
Major surgical complications were not remarkable in 
either group, and perioperative transfusion rates for RSS 
myomectomy were also similar to those for the conven-
tional multi-port method. Complications such as hernia 
or wound dehiscence, reported for larger umbilical inci-
sions, were not observed in the RSS myomectomy group. 
Concomitant surgeries with the single-site platform were 
also performed, including ovarian cyst enucleation, para-
tubal cystectomy, and cholecystectomy; however, these 
cases were not included in this analysis.
There are drawbacks to the RSS procedures that the 
surgeon must consider during the surgical process. The 
smaller angulation or the absence of wrist motion limits 
the approach to myomas located in certain areas, arbi-
trarily called the ‘blind spots’; for example, if the surgeon 
is right handed, myomas in the left lower segment of the 
uterus become difficult to tackle and a deep posterior 
approach is required. Although the maximal diameter of 
myomas removed did not differ between the two groups 
(Table 1), when a myoma was bulky enough such that the 
distance from the trocar to the target was below 8–10 cm, 
single-site robotic arm movements became extremely 
limited. Adjusting the location of the port placement 
cephalad is less likely to be an option for single-site sur-
gery, as placing a 2.5-cm incision above the umbilicus 
is not a preferred option. Moreover, the driving force of 
the needle driver is weaker, causing the needle to pivot in 
unwanted angles depending on the myometrial thickness 
and consistency; thus, more trial and error are required.
Careful selection of patients in the initial cases of RSS 
is required for trainees who have less experience with 
MIS, since the ergonomics may be different and they may 
require a longer learning curve compared with that for 
the conventional multi-port robotic platform. However, 
for an experienced MIS surgeon, the ergonomics have 
overlapping features in both conventional robotic sur-
gery and laparoscopic surgery, requiring minimal accom-
modation periods. Additional prospective studies with 
a larger number of patients across different institutions 
should be conducted for further validation.
Conclusions
In conclusion, Da Vinci single-site myomectomy with 
the use of wristed needle drivers is a compatible option 
with regard to reproducibility and safety, without being 
significantly different in the number of myomas and the 
total maximal diameter of myomas resected from the 
RMP method. The simplified nature of the single-site 
platform with less tool substitution and faster myoma 
extraction contributes to a shorter operative time with-
out compromising the intensive suturing process. In the 
RSS method, the advantage of feeling less pain with the 
same amount of analgesic drugs, as in the RMP method, 
may contribute to improving patient satisfaction.
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